|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.900 USD | -4.52% |
|
-13.64% | -11.63% |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | -1.51 | -3.08 | -9.43 | -2.73 | -0.26 | ||
Return on Total Capital | -1.9 | -3.8 | -12.84 | -4.02 | -0.39 | ||
Return On Equity % | -8.6 | -46.62 | -50.72 | -28.91 | -1.6 | ||
Return on Common Equity | -3.03 | -51.63 | -48.13 | -26.74 | -2.79 | ||
Margin Analysis | |||||||
Gross Profit Margin % | 77.3 | 77.47 | 70.29 | 78.36 | 83.65 | ||
SG&A Margin | 64.92 | 73.75 | 92.61 | 69.06 | 67.51 | ||
EBITDA Margin % | 5.94 | 0.04 | -28.6 | 3.94 | 11.47 | ||
EBITA Margin % | 5.61 | -0.83 | -29.62 | 3.41 | 11 | ||
EBIT Margin % | -5.11 | -9.68 | -44.51 | -9.39 | -0.77 | ||
Income From Continuing Operations Margin % | -11.08 | -50.28 | -59.58 | -20.59 | -0.92 | ||
Net Income Margin % | -5.05 | -17.82 | -23.54 | -8.61 | -0.37 | ||
Net Avail. For Common Margin % | -2.14 | -17.82 | -23.69 | -9.1 | -0.82 | ||
Normalized Net Income Margin | 0.52 | 24.47 | 2.59 | 0.2 | -5.57 | ||
Levered Free Cash Flow Margin | 17.19 | 1.63 | -14.37 | 10.71 | 11.61 | ||
Unlevered Free Cash Flow Margin | 19.26 | 3.39 | -9.18 | 16.19 | 16.19 | ||
Asset Turnover | |||||||
Asset Turnover | 0.47 | 0.51 | 0.34 | 0.47 | 0.53 | ||
Fixed Assets Turnover | 74.06 | 32.65 | 13.37 | 15.37 | 16.39 | ||
Receivables Turnover (Average Receivables) | 5.15 | 4.08 | 1.84 | 1.95 | 2.22 | ||
Short Term Liquidity | |||||||
Current Ratio | 3.08 | 1.98 | 1.56 | 1.29 | 1.18 | ||
Quick Ratio | 2.85 | 1.8 | 1.49 | 1.25 | 1.14 | ||
Operating Cash Flow to Current Liabilities | -0.9 | -1.38 | 0.23 | 0.29 | -0.06 | ||
Days Sales Outstanding (Average Receivables) | 71.03 | 89.54 | 198.23 | 186.94 | 164.52 | ||
Average Days Payable Outstanding | 20.5 | 37.04 | 53.48 | 37.72 | 45.25 | ||
Long Term Solvency | |||||||
Total Debt/Equity | 28.66 | 78.03 | 94.21 | 119.36 | 115.18 | ||
Total Debt / Total Capital | 22.28 | 43.83 | 48.51 | 54.41 | 53.53 | ||
LT Debt/Equity | 28.34 | 76.74 | 91.8 | 101.6 | 105.32 | ||
Long-Term Debt / Total Capital | 22.03 | 43.11 | 47.27 | 46.32 | 48.94 | ||
Total Liabilities / Total Assets | 33.65 | 56.86 | 64.34 | 69.66 | 69.2 | ||
EBIT / Interest Expense | -1.36 | -3.07 | -4.93 | -0.99 | -0.08 | ||
EBITDA / Interest Expense | 1.58 | 0.25 | -3.02 | 0.52 | 1.34 | ||
(EBITDA - Capex) / Interest Expense | 1.14 | -0.34 | -3.26 | 0.32 | 1.16 | ||
Total Debt / EBITDA | 7.7 | 82.22 | -3.23 | 14.99 | 5.39 | ||
Net Debt / EBITDA | 4.93 | 72.26 | -3.14 | 12.48 | 4.97 | ||
Total Debt / (EBITDA - Capex) | 10.67 | -61.46 | -3 | 24.13 | 6.27 | ||
Net Debt / (EBITDA - Capex) | 6.83 | -54.01 | -2.91 | 20.09 | 5.78 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | 62.62 | 21.09 | -40.54 | 16.31 | 8.74 | ||
Gross Profit, 1 Yr. Growth % | 83.31 | 21.37 | -46.06 | 29.66 | 16.08 | ||
EBITDA, 1 Yr. Growth % | -5.37 | -99.21 | -12.35T | -116.03 | 216.51 | ||
EBITA, 1 Yr. Growth % | -7.84 | -117.96 | 2.31T | -113.4 | 250.76 | ||
EBIT, 1 Yr. Growth % | -196.58 | 129.44 | 176.08 | -75.46 | -91.09 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | 136.68 | 449.58 | -29.54 | -59.81 | -95.16 | ||
Net Income, 1 Yr. Growth % | 7.79 | 327.76 | -21.47 | -57.46 | -95.37 | ||
Normalized Net Income, 1 Yr. Growth % | -81.02 | 5.65T | -93.72 | -90.87 | -3.07T | ||
Diluted EPS Before Extra, 1 Yr. Growth % | -2.57T | 701.5 | -33.88 | -59.42 | -90.82 | ||
Accounts Receivable, 1 Yr. Growth % | 71.26 | 42.19 | 24.2 | -2.01 | -7.17 | ||
Net Property, Plant and Equip., 1 Yr. Growth % | 173.75 | 175.08 | -2.03 | 4.43 | -0.41 | ||
Total Assets, 1 Yr. Growth % | 31.61 | -1.89 | -19.8 | -9.63 | -0.74 | ||
Tangible Book Value, 1 Yr. Growth % | 124.74 | -65.24 | -4.02 | -28.6 | -63.36 | ||
Common Equity, 1 Yr. Growth % | -55.77 | -7.18 | -23.89 | -14.04 | 4.69 | ||
Cash From Operations, 1 Yr. Growth % | 38.07L | 161.79 | -120.37 | 79.2 | -119.8 | ||
Capital Expenditures, 1 Yr. Growth % | 81.18 | 36.34 | -31.76 | 1.63 | -0.02 | ||
Levered Free Cash Flow, 1 Yr. Growth % | 19.85 | -88.55 | -602.6 | -186.69 | 17.89 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | 29.5 | -78.72 | -257.73 | -304.99 | 8.78 | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % | 96.94 | 40.33 | -15.15 | -16.84 | 12.46 | ||
Gross Profit, 2 Yr. CAGR % | 115.06 | 49.16 | -19.08 | -16.37 | 22.68 | ||
EBITDA, 2 Yr. CAGR % | 31.09 | -92.64 | 86.19 | 343.06 | -28.77 | ||
EBITA, 2 Yr. CAGR % | 30.8 | -65.59 | 94.98 | 79.53 | -31.45 | ||
EBIT, 2 Yr. CAGR % | 24.87 | 48.86 | 150.38 | -17.69 | -85.21 | ||
Earnings From Cont. Operations, 2 Yr. CAGR % | 85.94 | 260.66 | 96.78 | -46.79 | -86.06 | ||
Net Income, 2 Yr. CAGR % | 25.47 | 114.73 | 83.28 | -42.2 | -85.97 | ||
Normalized Net Income, 2 Yr. CAGR % | -49.31 | 230.34 | 90.26 | -92.43 | 64.82 | ||
Diluted EPS Before Extra, 2 Yr. CAGR % | - | 1.31T | 129.98 | -48.2 | -80.7 | ||
Accounts Receivable, 2 Yr. CAGR % | 110.46 | 56.13 | 32.89 | 10.32 | -4.63 | ||
Net Property, Plant and Equip., 2 Yr. CAGR % | 21.36 | 174.42 | 64.16 | 1.15 | 1.98 | ||
Total Assets, 2 Yr. CAGR % | 284.24 | 13.63 | -11.3 | -14.86 | -5.29 | ||
Tangible Book Value, 2 Yr. CAGR % | 92.94 | -11.61 | -42.24 | -17.22 | -48.85 | ||
Common Equity, 2 Yr. CAGR % | 42.76 | -35.93 | -15.95 | -19.12 | -5.14 | ||
Cash From Operations, 2 Yr. CAGR % | 358.09 | 31.47T | -26.98 | -39.58 | -40.44 | ||
Capital Expenditures, 2 Yr. CAGR % | 53.42 | 57.17 | -3.54 | -16.72 | 0.8 | ||
Levered Free Cash Flow, 2 Yr. CAGR % | - | -62.92 | -22.48 | 108.73 | 1.09 | ||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | -47.46 | -41.46 | 79.81 | 49.33 | ||
Compound Annual Growth Rate Over Three Years | |||||||
Total Revenues, 3 Yr. CAGR % | - | 67.47 | 5.4 | -5.74 | -9.06 | ||
Gross Profit, 3 Yr. CAGR % | - | 77.72 | 6.27 | -5.31 | -6.71 | ||
EBITDA, 3 Yr. CAGR % | - | -76.12 | 33.27 | -17.79 | 296.07 | ||
EBITA, 3 Yr. CAGR % | - | -32.52 | 35.83 | -20.14 | 124.44 | ||
EBIT, 3 Yr. CAGR % | - | 52.94 | 82.26 | 15.44 | -60.77 | ||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | 166.84 | 109.27 | 15.89 | -76.07 | ||
Net Income, 3 Yr. CAGR % | - | 88.84 | 53.56 | 12.64 | -75.09 | ||
Normalized Net Income, 3 Yr. CAGR % | - | 145.36 | -11.76 | -30.86 | -44.54 | ||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | 407.42 | 29 | -70.9 | ||
Accounts Receivable, 3 Yr. CAGR % | - | 84.74 | 44.67 | 20.06 | 4.15 | ||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | 59.42 | 94.67 | 41.19 | 0.63 | ||
Total Assets, 3 Yr. CAGR % | - | 143.76 | 1.17 | -10.74 | -10.4 | ||
Tangible Book Value, 3 Yr. CAGR % | - | 8.98 | -9.15 | -38.01 | -36.91 | ||
Common Equity, 3 Yr. CAGR % | - | 23.68 | -32.14 | -15.32 | -11.85 | ||
Cash From Operations, 3 Yr. CAGR % | - | 280.14 | 2.63T | -1.5 | -58.35 | ||
Capital Expenditures, 3 Yr. CAGR % | - | 47.5 | 19.01 | -1.85 | -11.49 | ||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | -10.3 | -19.54 | 72.54 | ||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | -23.67 | -11.1 | 52.08 | ||
Compound Annual Growth Rate Over Five Years | |||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | 26.57 | 8.17 | ||
Gross Profit, 5 Yr. CAGR % | - | - | - | 31.46 | 12.55 | ||
EBITDA, 5 Yr. CAGR % | - | - | - | -0.92 | 3.73 | ||
EBITA, 5 Yr. CAGR % | - | - | - | -2.72 | 3.32 | ||
EBIT, 5 Yr. CAGR % | - | - | - | 19.12 | -33.26 | ||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | 40.01 | -29.17 | ||
Net Income, 5 Yr. CAGR % | - | - | - | 17.61 | -41.03 | ||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | -38.93 | 13.29 | ||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | - | 37.23 | ||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | 50.31 | 22.46 | ||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 32.89 | 50.31 | ||
Total Assets, 5 Yr. CAGR % | - | - | - | 60.04 | -1.46 | ||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | -2.37 | -27.8 | ||
Common Equity, 5 Yr. CAGR % | - | - | - | 4.36 | -22.41 | ||
Cash From Operations, 5 Yr. CAGR % | - | - | - | 82.15 | 490.87 | ||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | 17.35 | 11.36 | ||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | -5.91 | ||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | -0.17 |
- Stock Market
- Equities
- GOCO Stock
- Financials GoHealth, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















